(CSL:Australian Stock Exchange Ltd)
David Westbrook Anstice
Independent Director, Member of Nomination Committee, Member of Human Resources & Remuneration Committee and Member of Innovation & Development Committee, CSL Ltd.
|Age||Total Calculated Compensation||This person is connected to 135 board members in 6 different organizations across 5 different industries.|
See Board Relationships
Mr. David Westbrook Anstice served as the President of MSD K.K. Mr. Anstice served as Executive Vice President of Strategy Initiatives at Merck & Co. Inc., from September 2006 to September 2008. He served as the President of Human Health of Merck & Co., Inc. from January 2003 to September 2006 and was responsible for its prescription drug business in Japan, Latin America, Canada, Australia, New Zealand and its joint venture relationship with Schering-Plough. He spent ...
45 Poplar RoadPhone: 61 3 9389 1911
Parkville, Victoria 3052
Fax: 61 3 9389 1434
Board Members Memberships*
Independent Director, Member of Nomination Committee, Member of Human Resources & Remuneration Committee and Member of Innovation & Development Committee
Independent Director, Chairman of Compensation Committee and Member of Limited Compensation Sub Committee
Bachelor's Degree 1970
University Of Sydney
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
|Jean-Jacques Bienaime MBA||Chief Executive Officer and Director|
BioMarin Pharmaceutical Inc.
|David M. Stack||Chairman, Chief Executive Officer and President|
Pacira Pharmaceuticals, Inc.
|Thomas W. D'Alonzo Esq., J.D.||Chairman, Acting Chief Executive Officer, Acting President, Member of Audit Committee, Member of Nominating/Corporate Governance Committee and Member of Compensation Committee|
Salix Pharmaceuticals Ltd.
|Vinita Gupta||Chief Executive Officer, Executive Director, Chief Executive Officer of Lupin Pharmacuticls Inc Usa and Group President of Lupin Pharmacuticls Inc Usa|
|Alessandro E. Della Chà LL.M||Chief Executive Officer and Director|
Cosmo Pharmaceuticals S.p.A.
|--||Compensation as of Fiscal Year 2013.|